159 related articles for article (PubMed ID: 28563699)
1. Stability and crystal structures of His88 mutant human transthyretins.
Yokoyama T; Hanawa Y; Obita T; Mizuguchi M
FEBS Lett; 2017 Jul; 591(13):1862-1871. PubMed ID: 28563699
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen-bond network and pH sensitivity in transthyretin: Neutron crystal structure of human transthyretin.
Yokoyama T; Mizuguchi M; Nabeshima Y; Kusaka K; Yamada T; Hosoya T; Ohhara T; Kurihara K; Tomoyori K; Tanaka I; Niimura N
J Struct Biol; 2012 Feb; 177(2):283-90. PubMed ID: 22248451
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen-bond network and pH sensitivity in human transthyretin.
Yokoyama T; Mizuguchi M; Nabeshima Y; Kusaka K; Yamada T; Hosoya T; Ohhara T; Kurihara K; Tanaka I; Niimura N
J Synchrotron Radiat; 2013 Nov; 20(Pt 6):834-7. PubMed ID: 24121323
[TBL] [Abstract][Full Text] [Related]
4. Quaternary structure, aggregation and cytotoxicity of transthyretin.
Mizuguchi M; Yokoyama T; Nabeshima Y; Kawano K; Tanaka I; Niimura N
Amyloid; 2012 Jun; 19 Suppl 1():5-7. PubMed ID: 22439750
[TBL] [Abstract][Full Text] [Related]
5. Conformational differences between the wild type and V30M mutant transthyretin modulate its binding to genistein: implications to tetramer stability and ligand-binding.
Trivella DB; Bleicher L; Palmieri Lde C; Wiggers HJ; Montanari CA; Kelly JW; Lima LM; Foguel D; Polikarpov I
J Struct Biol; 2010 Jun; 170(3):522-31. PubMed ID: 20211733
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the structure, thermodynamic stability, and aggregation properties of the A25T transthyretin (A25T-TTR) variant involved in leptomeningeal amyloidosis: identifying protein partners that co-aggregate during A25T-TTR fibrillogenesis in cerebrospinal fluid.
Azevedo EP; Pereira HM; Garratt RC; Kelly JW; Foguel D; Palhano FL
Biochemistry; 2011 Dec; 50(51):11070-83. PubMed ID: 22091638
[TBL] [Abstract][Full Text] [Related]
7. The beta-strand D of transthyretin trapped in two discrete conformations.
Hörnberg A; Olofsson A; Eneqvist T; Lundgren E; Sauer-Eriksson AE
Biochim Biophys Acta; 2004 Jul; 1700(1):93-104. PubMed ID: 15210129
[TBL] [Abstract][Full Text] [Related]
8. Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis.
Hurshman Babbes AR; Powers ET; Kelly JW
Biochemistry; 2008 Jul; 47(26):6969-84. PubMed ID: 18537267
[TBL] [Abstract][Full Text] [Related]
9. Structural insight into pH-induced conformational changes within the native human transthyretin tetramer.
Palaninathan SK; Mohamedmohaideen NN; Snee WC; Kelly JW; Sacchettini JC
J Mol Biol; 2008 Oct; 382(5):1157-67. PubMed ID: 18662699
[TBL] [Abstract][Full Text] [Related]
10. Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution.
Sebastião MP; Lamzin V; Saraiva MJ; Damas AM
J Mol Biol; 2001 Mar; 306(4):733-44. PubMed ID: 11243784
[TBL] [Abstract][Full Text] [Related]
11. AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.
Penchala SC; Connelly S; Wang Y; Park MS; Zhao L; Baranczak A; Rappley I; Vogel H; Liedtke M; Witteles RM; Powers ET; Reixach N; Chan WK; Wilson IA; Kelly JW; Graef IA; Alhamadsheh MM
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9992-7. PubMed ID: 23716704
[TBL] [Abstract][Full Text] [Related]
12. Potentially amyloidogenic conformational intermediates populate the unfolding landscape of transthyretin: insights from molecular dynamics simulations.
Rodrigues JR; Simões CJ; Silva CG; Brito RM
Protein Sci; 2010 Feb; 19(2):202-19. PubMed ID: 19937650
[TBL] [Abstract][Full Text] [Related]
13. A comparative analysis of 23 structures of the amyloidogenic protein transthyretin.
Hörnberg A; Eneqvist T; Olofsson A; Lundgren E; Sauer-Eriksson AE
J Mol Biol; 2000 Sep; 302(3):649-69. PubMed ID: 10986125
[TBL] [Abstract][Full Text] [Related]
14. Disease-associated mutations impacting BC-loop flexibility trigger long-range transthyretin tetramer destabilization and aggregation.
Esperante SA; Varejāo N; Pinheiro F; Sant'Anna R; Luque-Ortega JR; Alfonso C; Sora V; Papaleo E; Rivas G; Reverter D; Ventura S
J Biol Chem; 2021 Sep; 297(3):101039. PubMed ID: 34343569
[TBL] [Abstract][Full Text] [Related]
15. Retention of misfolded mutant transthyretin by the chaperone BiP/GRP78 mitigates amyloidogenesis.
Sörgjerd K; Ghafouri B; Jonsson BH; Kelly JW; Blond SY; Hammarström P
J Mol Biol; 2006 Feb; 356(2):469-82. PubMed ID: 16376939
[TBL] [Abstract][Full Text] [Related]
16. Role of the glutamic acid 54 residue in transthyretin stability and thyroxine binding.
Miyata M; Sato T; Mizuguchi M; Nakamura T; Ikemizu S; Nabeshima Y; Susuki S; Suwa Y; Morioka H; Ando Y; Suico MA; Shuto T; Koga T; Yamagata Y; Kai H
Biochemistry; 2010 Jan; 49(1):114-23. PubMed ID: 19950966
[TBL] [Abstract][Full Text] [Related]
17. Nearly 200 X-ray crystal structures of transthyretin: what do they tell us about this protein and the design of drugs for TTR amyloidoses?
Palaninathan SK
Curr Med Chem; 2012; 19(15):2324-42. PubMed ID: 22471981
[TBL] [Abstract][Full Text] [Related]
18. Modulation of human transthyretin stability by the mutations at histidine 88 studied by free energy simulation.
Lee KH; Kuczera K
Proteins; 2022 Nov; 90(11):1825-1836. PubMed ID: 35484710
[TBL] [Abstract][Full Text] [Related]
19. Effect of alanine versus serine at position 88 of human transthyretin mutants on the protein stability.
Lee KH; Kuczera K
Protein Eng Des Sel; 2023 Jan; 36():. PubMed ID: 36611015
[TBL] [Abstract][Full Text] [Related]
20. The binding of 2,4-dinitrophenol to wild-type and amyloidogenic transthyretin.
Morais-de-Sá E; Neto-Silva RM; Pereira PJ; Saraiva MJ; Damas AM
Acta Crystallogr D Biol Crystallogr; 2006 May; 62(Pt 5):512-9. PubMed ID: 16627944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
